NIDA Neuroscience funding opportunities
I. NIDA's Division of Neuroscience and Behavior Research Programmatic Interests
NIDA has a very broad range of programmatic interests in basic science, someof which are described below. :
Cellular, Molecular, and Developmental Neuroscience and Genetics -NIDA supports research on basic neurobiology and the fundamental cellular mechanisms that underlie addiction and the response to drugs of abuse, and has a broad portfolio including numerous grants on topics such as protein trafficking, synaptic vesicle formation, regulation of neural gene expression, regulation of receptors transport proteins, signal transduction,synaptic plasticity, axonal guidance of dopamine neurons, neural development and learning. Researchers with interests in these areas or in the area of genetics should contact NIDA program officials Dr. Jonathan Pollock (301-435-1309; jp183r@nih.gov) or Dr. Rebekah Rasooly (301-443-6300; rr185i@nih.gov).
Chemical and Physiological Systems - scientists working in the areas of the effects of perinatal drug exposure on neural systems and other organs; pharmacological aspects of exposure to drugs of abuse in utero; effects of drugs of abuse on physiological systems outside of the CNS; neuroimmune function; endocrinology; analytical methods including analytical proteomics; basic chemistry such as the study of structure activity relationships, and chemical synthesis of ligands for all drugs of abuse and receptor types and subtypes, synthesis of analgesics with minimal side effects, conformation of ligands , receptors, transporters, ion channels and protein folding, structure-function relationships; identification of pharmacophores and to discover new templates; modeling and conformational studies and related structural biology studies using advanced biophysical methods; and pharmacokinetics (drug absorption, distribution, metabolism and elimination), pharmacodynamics and targeted drug delivery. Dr. Rao Rapaka (301-443-6300; rr82u@nih.gov).
Pharmacology, Integrative and Cellular Neurobiology - researchers with interests in neuropharmacology, neurotoxicology and the regulatory elements of neural transmission (analysis of single proteins, single cells, or circuit-level studies within neuronal systems) or in neuroendocrinology (i.e., neurosteroids or neuroactive steroids or neuropeptide hormones on neurotransmission), and signal transduction systems should please contact Dr. Nancy Pilotte (301-443-1317; np22f@nih.gov).
Behavioral and Cognitive Science - investigators interested in applying for support of basic research on behavioral and cognitive factors related to antecedents, consequences and the transition to addiction, including (but not limited to) the study of decision processes, associative processes, attention and neurobiological substrates of behavior. Research is also supported that uses electrophysiological approaches, examines neuroethological model systems, and employs computational modeling of neural networks. Applicants should contact Dr. Minda Lynch (301-443-1263, mlynch1@nida.nih.gov).
Translating Basic Research into Applications Research - NIDA's newly-developed Translational Research Branch (TRB) was designed to facilitate the transformation of basic research data into clinical tools and medications. Some areas of special current interest to the TRB are the development of cognitive and pharmacological interventions for drug abuse that target frontal lobe function, the development of advanced neuroimaging tools, the development of treatments that target tobacco abuse, and the development of novel pain treatments. Investigators planning to apply for support for research in these areas should contact Dr. David Thomas (301-435-1313; dt78k@nih.gov).
II. Administrative Supplements
For Developing Computational andTheoretical Models in Drug Abuse and Addiction- The National Institute on Drug Abuse (NIDA) announces the availability of funds to supplement existing NIDA-supported research projects to develop and incorporate computational and theoretical modeling approaches in ongoing research. NIDA-funded researchers studying behavioral, cognitive and neurobiological processes, and cellular and molecular mechanisms of drug abuse and addiction would be eligible for supplemental funding. Applications Due May 3, 2001. http://www.nida.nih.gov/Funding/modeling-supplement.html For more information contact Dr. David Shurtleff (301-443-1887, ds171a@nih.gov).
To Study Issues Related To The Transition From Drug Use To Addiction -The National Institute on Drug Abuse (NIDA) announces the availability of funds to supplement existing NIDA-supported research project grants to study issues related to the transition from drug use to addiction. Applications should be submitted no later than June 1, 2001. http://www.nida.nih.gov/Funding/AddictionGrant.html For more information contact Dr. Steven Gust (301-443-6480, sgust@nih.gov)
III. Complete List of NIDA-supported Research
A complete listing of NIDA-supported research can be found by searching the CRISP database at https://www-commons.cit.nih.gov/crisp/index.html
IV. Frequently Asked Questions About the NIH grant Application Process
To assist you in preparing you application, a list of frequently asked
questions about the NIH grant application process has been prepared by NIDA's Office of Extramural Affairs (http://www.nida.nih.gov/OEA/OEAFAQ.html)
